Cytek Biosciences Inc Cash Flow Quality Index
Cytek Biosciences Inc cash flow quality index. Cytek Biosciences Inc (CTKB) has a Cash Flow Quality Index of 0.21x as of December 2024. Operating cash flow of $2.00 Million is below net income of $9.64 Million, suggesting accrual-heavy earnings not yet converted to cash. See Cytek Biosciences Inc financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of Cytek Biosciences Inc (2020–2022)
Cash flow quality index of Cytek Biosciences Inc from 2020 to 2022. Historical Cash Flow Quality Index for Cytek Biosciences Inc across 3 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of Cytek Biosciences Inc to assess how comfortably operating cash covers total debt obligations.
Cytek Biosciences Inc Cash Flow Quality Index by Year (2020–2022)
Cytek Biosciences Inc cash flow quality index by year from 2020 to 2022. Year-by-year earnings quality comparison for Cytek Biosciences Inc. For the full cash flow conversion analysis, see CTKB cash flow metrics.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2022 | -4.92x | $-12.23 Million | $2.48 Million | ▼ -421.9% |
| 2021 | 1.53x | $4.63 Million | $3.03 Million | ▲ +95.9% |
| 2020 | 0.78x | $15.16 Million | $19.41 Million | — |